Inhibikase Therapeutics, Inc.
IKTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Inhibikase Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Inhibikase Therapeutics, Inc. — 10-K filed Mar 27, 2025
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 30, 2026. The latest institutional report shown is dated Sep 30, 2022; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| StoneX Group Inc. | 2022-09-30 | 13,313 | $12.1K | SEC filing |
1 filer has only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Inhibikase Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-11-21 · Sands Capital Alternatives, LLC: Larger than all 12 other insider purchases of Common Stock on file. SEC filing
- 2024-10-21 · Bellini Roberto: Larger than 11 of the 12 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2024-10-21–2024-10-21: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2022-05-19–2022-05-20: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-21 | Sands Capital Alternatives, LLC · 10% owner | Common Stock | P — Open market or private purchase | +2,068,965 | 1.45 | SEC filing |
| 2024-10-21 | Bellini Roberto · Director | Common Stock | P — Open market or private purchase | +1,460,000 | 1.37 | SEC filing |
| 2024-10-21 | Munshi Amit · Director | Common Stock | P — Open market or private purchase | +365,000 | 1.37 | SEC filing |
| 2024-10-21 | Kush Arvind · Director | Common Stock | P — Open market or private purchase | +145,000 | 1.37 | SEC filing |
| 2022-08-16 | Werner Milton H. · President and CEO | Common Stock | P — Open market or private purchase | +5,000 | 0.80 | SEC filing |
| 2022-05-27 | Werner Milton H. · President and CEO | Common Stock | P — Open market or private purchase | +5,000 | 0.98 | SEC filing |
| 2022-05-20 | Werner Milton H. · President and CEO | Common Stock | P — Open market or private purchase | +10,000 | 0.60 | SEC filing |
| 2022-05-19 | FRATTAROLI JOSEPH · Chief Financial Officer | Common Stock | P — Open market or private purchase | +3,948 | 0.64 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-26 | Canner David · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +155,000 | SEC filing |
| 2026-06-26 | Munshi Amit · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +155,000 | SEC filing |
| 2026-06-26 | Aurentz Vincent · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +155,000 | SEC filing |
| 2026-06-26 | BERMAN DENNIS N · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +155,000 | SEC filing |
| 2026-06-26 | Bellini Roberto · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +155,000 | SEC filing |
| 2026-06-26 | Kush Arvind · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +155,000 | SEC filing |
| 2026-01-05 | McIntyre David · Chief Financial Officer | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +986,319 | SEC filing |
| 2026-01-05 | Cabell Christopher · President & Head of R&D | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +900,117 | SEC filing |
Showing 8 of 19 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-02-21 | Aurentz Vincent · Director | Common Stock | D — Disposition to the issuer | −255,299 | SEC filing |
| 2026-02-21 | Cabell Christopher · President & Head of R&D | Common Stock | D — Disposition to the issuer | −338,282 | SEC filing |
| 2026-02-21 | Munshi Amit · Director | Common Stock | D — Disposition to the issuer | −19,089 | SEC filing |
| 2025-01-21 | Freeman Roy Lester · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −3,780 | SEC filing |
| 2025-01-21 | Freeman Roy Lester · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −6,667 | SEC filing |
| 2025-01-21 | BERMAN DENNIS N · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −1,138 | SEC filing |
| 2025-01-21 | Werner Milton H. · President and CEO | Stock Option (Right to Buy) | D — Disposition to the issuer | −20,834 | SEC filing |
| 2025-01-21 | Werner Milton H. · President and CEO | Stock Option (Right to Buy) | D — Disposition to the issuer | −16,667 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.